Physician

Firas M.a. Hamdan, M.D.

According to 2025 Medicare claims, Firas Hamdan, M.D. (NPI: 1780623645) practices cardiac electrophysiology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is AULTMAN DEUBLE HEART & VASCULAR HOSPITAL, LLC (NPI: 1306495718; TIN: 84-2848226) and primary practice location at 44710-1702. Hamdan is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729) and IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Hamdan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 3,047 HCPCS/CPT codes, and received $166,485 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,610 prescription claims across 463 beneficiaries totaling $484,256 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 13 claims. Open Payments data shows 31 records totaling $2,196. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	775	2,391	$188,870
2016	755	2,766	$210,777
2017	1,192	3,428	$215,464
2018	1,347	4,279	$215,024
2019	1,055	3,723	$206,072
2020	833	3,502	$161,003
2021	781	3,169	$161,177
2022	717	3,123	$161,067
2023	730	3,117	$159,971
2024	722	3,047	$166,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	526	3,504	$366,902
2016	478	3,113	$495,433
2017	601	3,102	$601,120
2018	715	4,071	$935,170
2019	646	3,637	$951,713
2020	607	3,478	$1,007,031
2021	483	2,306	$673,403
2022	410	1,687	$450,468
2023	463	1,928	$536,815
2024	463	1,610	$484,256

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$24,106
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	206	240	$88
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	116	260	$24
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	180	423	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	294	680	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	277	325	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	294	15,251	$291,037
Xarelto	Rivaroxaban	131	6,644	$118,508
Dofetilide	Dofetilide	96	8,280	$21,010
Multaq	Dronedarone Hcl	13	690	$18,129
Sotalol	Sotalol Hcl	267	19,936	$6,255

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$2,196	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Firas M.a. Hamdan, M.D.?

Tedicare shows public-source Medicare data for Firas M.a. Hamdan, M.D. (NPI 1780623645), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Firas M.a. Hamdan, M.D. have ACO affiliation data?

Firas M.a. Hamdan, M.D. is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729) and IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Firas M.a. Hamdan, M.D.?

Firas M.a. Hamdan, M.D. is linked to AULTMAN DEUBLE HEART & VASCULAR HOSPITAL, LLC (billing NPI 1306495718) in the available physician profile data.

Does Firas M.a. Hamdan, M.D. have Open Payments data?

Firas M.a. Hamdan, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.